Genetics, insurance and hypertrophic cardiomyopathy
Year of publication: |
2021
|
---|---|
Authors: | Haçarız, Oytun ; Kleinow, Torsten ; Macdonald, Angus |
Published in: |
Scandinavian actuarial journal. - Stockholm : Taylor & Francis, ISSN 1651-2030, ZDB-ID 2029609-5. - Vol. 2021.2021, 1, p. 54-81
|
Subject: | Adverse selection | cascade genetic testing | genetic epidemiology | hypertrophic cardiomyopathy | life insurance | mortality | Lebensversicherung | Life insurance | Sterblichkeit | Mortality | Adverse Selektion | Gentechnik | Genetic engineering | Theorie | Theory | Krankenversicherung | Health insurance | Genetik | Genetics | Risikomodell | Risk model | Versicherungsbeitrag | Insurance premium |
-
An actuarial model of arrhythmogenic right ventricular cardiomyopathy and life insurance
Haçarız, Oytun, (2022)
-
Genetic testing and actuarial science
Macdonald, Angus, (2024)
-
Private information in life insurance, annuity, and health insurance markets
Wuppermann, Amelie, (2017)
- More ...
-
An actuarial model of arrhythmogenic right ventricular cardiomyopathy and life insurance
Haçarız, Oytun, (2022)
-
Will genetic test results be monetized in life insurance?
Haçarız, Oytun, (2020)
-
A hierarchical model for the joint mortality analysis of pension scheme data with missing covariates
Ungolo, Francesco, (2020)
- More ...